Fenofibrate is a lipid-lowering agent commonly marketed under various brand names and primarily used to manage hypercholesterolemia and hypertriglyceridemia. It works by activating peroxisome proliferator-activated receptor alpha (PPARα), which helps reduce triglycerides and increase HDL cholesterol levels. Ensuring the pharmaceutical purity of Fenofibrate is essential for maintaining its therapeutic effectiveness, minimizing adverse effects, and meeting regulatory standards. Impurity profiling is crucial to detect and control unwanted substances formed during manufacturing, storage, or degradation. Here are some of its known impurities listed below.
Showing 1 - 5 of 5 products
Catalogue No : FENO-OCL-001
CAS No : 49562-28-9
In Stock
Synonyms
Isopropyl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate
Isopropyl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate
Catalogue No : FENO-OCL-002
CAS No : 61001-99-8
In Stock
Synonyms
Isopropyl 2-(4-((4-chlorophenyl)(hydroxy)methyl)phenoxy)-2-methylpropanoate
Isopropyl 2-(4-((4-chlorophenyl)(hydroxy)methyl)phenoxy)-2-methylpropanoate
Catalogue No : FENO-OCL-003
CAS No : 42019-78-3
In Stock
Synonyms
(4-Chlorophenyl)(4-hydroxyphenyl)methanone
(4-Chlorophenyl)(4-hydroxyphenyl)methanone
Catalogue No : FENO-OCL-005
CAS No : 42017-89-0
In Stock
Synonyms
2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid
2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid
Catalogue No : FENO-OCL-004
CAS No : 154356-96-4
In Stock
Synonyms
(4-Chlorophenyl)[4-(1-methylethoxy)phenyl]methanone
(4-Chlorophenyl)[4-(1-methylethoxy)phenyl]methanone